Plant virus expression vectors set the stage as production platforms for biopharmaceutical proteins

Virology

Volumn 433, Issue 1, 2012, Pages 1-6

  Hefferon, Kathleen Laura ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

CPMV; Geminivirus; Plant derived biopharmaceutical; PVX; TMV; Vaccine; Virus Expression Vector

Indexed keywords

ENVELOPE PROTEIN; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VEGETABLE PROTEIN; VIRUS VACCINE;

3' UNTRANSLATED REGION; COWPEA MOSAIC VIRUS; DENGUE VIRUS; EXPRESSION VECTOR; GEMINIVIRUS; GENE SILENCING; HUMAN; IMMUNE RESPONSE; MOSAIC VIRUS; NONHUMAN; PLANT VIRUS; POTEXVIRUS; PRIORITY JOURNAL; REVIEW; RHIZOBIUM; TOBACCO MOSAIC VIRUS; TRANSGENE; VIRUS CELL TRANSFORMATION; VIRUS EXPRESSION;

ANTIBODIES, MONOCLONAL; COMOVIRUS; EPITOPES; GEMINIVIRIDAE; GENETIC VECTORS; HUMANS; PLANTS; POTEXVIRUS; RECOMBINANT PROTEINS; TOBACCO MOSAIC VIRUS; VACCINES, SYNTHETIC;

COWPEA MOSAIC VIRUS; GEMINIVIRIDAE; POTATO VIRUS X; TOBACCO MOSAIC VIRUS;

EID: 84866171113     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.06.012     Document Type: Review

References (51)

1. Azhakanandum K., Weissinger S.M., Nicholson J.S., et al. Amplicon-plus targeting technology (APTT) for rapid production of a highly unstable vaccine protein in tobacco plants. Plant Moll. Biol. 2007, 63:393-404.
2. Boehm R. Bioproduction of therapeutic proteins in the 21st century and the role of plants and plant cells as production platforms. Ann. N.Y. Acad. Sci. 2007, 1102:121-134.
3. Canizares M.C., Nicholson L., Lomonossoff G.P. Use of viral vectors for vaccine production in plants. Immunol. Cell. Biol. 2005, 83(3):263-270.
4. Canizares M.C., Lomonossoff G.P., Nicholson L. Development of cowpea mosaic virus-based vectors for the production of vaccines in plants. Expert Rev. Vaccines 2005, 4(5):687-697.
5. Chen Q., He J., Phoolcharoen W., et al. Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants. Hum. Vaccin. 2011, 7(3):331-338.
6. Chichester J.A., Musiychuk K., Farrance C.E., et al. A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague. Vaccine 2009, 27:3471-3474.
7. Chung H.Y., Lee H.H., Kim K.I., et al. Expression of a recombinant chimeric protein of hepatitis A virus VP1-Fc using a replicating vector based on Beet curly top virus in tobacco leaves and its immunogenicity in mice. Plant Cell. Rep. 2011, 30(8):1513-1521.
8. Daniell H., Singh N.D., Mason H., et al. Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci. 2009, 14(12):669-679.
9. Desai P.N., Shrivastava N., Padh H. Production of heterologous proteins in plants: strategies for optimal expression. Biotechnol. Adv. 2010, 28(4):427-435.
10. Gils M., Kandzia R., Marillonnet S., et al. High-yield production of authentic human growth hormone using a plant virus-based expression system. Plant Biotechnol. J. 2005, 3(6):613-620.
11. Gleba Y., Marillonnet S., Klimyuk V. Engineering viral expression vectors for plants: the 'full virus' and the 'deconstructed virus' strategies. Curr. Opin. Plant Biol. 2004, 7(2):182-188.
12. Gopinath K., Wellink J., Porta C., et al. Engineering cowpea mosaic virus RNA-2 into a vector to express heterologous proteins in plants. Virology 2000, 267(2):159-173.
13. Hefferon K.L., Fan Y. Expression of a vaccine protein in a plant cell line using a geminivirus-based replicon system. Vaccine 2004, 23(3):404-410.
14. Huang Z., LePore K., Elkin G., et al. High-yield rapid production of hepatitis B surface antigen in plant leaf by a viral expression system. Plant Biotechnol. J. 2008, 6(2):202-209.
15. Huang Z., Chen Q., Hjelm B., et al. A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnol. Bioeng. 2009, 103(4):706-714.
16. Huang Z., Phoolcharoen W., Lai H., et al. High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnol. Bioeng. 2010, 106(1):9-17.
17. Kim K.I., Sunter G., Bisaro D.M., et al. Improved expression of recombinant GFP using a replicating vector based on Beet curly top virus in leaf-disks and infiltrated Nicotiana benthamiana leaves. Plant Mol. Biol. 2007, 64(1-2):103-112.
18. Koprowski H., Yusibov V. The green revolution: plants as heterologous expression vectors. Vaccine 2001, 19:2735-2741.
19. Kumangai M.H., Turpen T.H., Weizenttl N., et al. Rapid, high-level expression of biologically active alpha-trichosanthin in transfected plants by an RNA viral vector. Proc. Natl. Acad. Sci. U.S.A 1993, 90(2):427-430.
20. Lim H.S., Vaira A.M., Domier L.L., et al. Efficiency of VIGS and gene expression in a novel bipartite potexvirus vector delivery system as a function of strength of TGB1 silencing suppression. Virology 2010, 402(1):149-163.
21. Lindbo J.A. High-efficiency protein expression in plants from agroinfection-compatible Tobacco mosaic virus expression vectors. BMC Biotechnol. 2007, 7:52.
22. Lindbo J.A. TRBO: a high-efficiency tobacco mosaic virus RNA-based overexpression vector. Plant Physiol. 2007, 145(4):1232-1240.
23. Lomonossoff G.P., Hamilton W.D. Cowpea mosaic virus-based vaccines. Curr. Top. Microbiol. Immunol. 1999, 240:177-189.
24. Mallory A.C., Parks G., Endres M.W., et al. The amplicon-plus system for high-level expression of transgenes in plants. Nat. Biotechnol. 2002, 20(6):622-625.
25. Matic S., Rinaldi R., Masenga V., et al. Efficient production of chimeric Human papillomavirus 16 L1 protein bearing the M2e influenza epitope in Nicotiana benthamiana plants. BMC Biotechnol. 2011, 11(1):106.
26. Massa S., Franconi R., Brandi R., et al. Anti-cancer activity of plant-produced HPV16 E7 vaccine. Vaccine 2007, 25(16):3018-3021.
27. McCormick A.A., Reddy S., Reinl S.J., et al. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(29):10131-10136.
28. Mett V., Musiychuk K., Bi H., et al. A plant-produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respir. Viruses 2008, 2(1):33-40.
29. Molina A., Hervás-Stubbs S., Daniell H., et al. High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol. J. 2004, 2:141-153.
30. Musiychuk K., Stephenson N., Bi H., et al. A launch vector for the production of vaccine antigens in plants. Influenza Other Respir. Viruses 2007, 1(1):19-25.
31. Noris E., Poli A., Cojoca R., et al. A human papillomavirus 8 E7 protein produced in plants is able to trigger the mouse immune system and delay the development of skin lesions. Arch. Virol. 2011, 156(4):587-595.
32. Paul M., Ma J.K. Plant-made pharmaceuticals: leading products and production platforms. Biotechnol. Appl. Biochem. 2011, 58(1):58-67.
33. Penney C.A., Thomas D.R., Deen S.S., et al. Plant-made vaccines in support of the Millennium Development Goals. Plant Cell Rep. 2011, 30(5):789-798.
34. Péres-Filgueira D.M., Zamorano P.I., Dominguez M.G., et al. Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity. Vaccine 2003, 21:4201-4204.
35. Regnard G.L., Halley-Stott R.P., Tanzer F.L., et al. High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector. Plant Biotechnol. J. 2010, 8(1):38-46.
36. Rybicki E.P. Plant-produced vaccines: promise and reality. Drug Discov. Today 2009, 14(1-2):16-24.
37. Rybicki E.P. Plant-made vaccines for humans and animals. Plant Biotechnol. J. 2010, 8(5):620-637.
38. Saejung W., Fujiyama K., Takasaki T., et al. Production of dengue 2 envelope domain III in plant using TMV-based vector system. Vaccine 2007, 25(36):6646-6654.
39. Sainsbury F., Lomonossoff G.P. Extremely high-level and rapid transient protein production in plants without the use of viral replication. Plant Physiol. 2008, 148(3):1212-1218.
40. Sainsbury F., Sack M., Stadlmann J., et al. Rapid transient production in plants by replicating and non-replicating vectors yields high quality functional anti-HIV antibody. PLoS One 2010, 5(11):e13976.
41. Sainsbury F., Cañizares M.C., Lomonossoff G.P. Cowpea mosaic virus: the plant virus-based biotechnology workhorse. Annu. Rev. Phytopathol. 2010, 48:437-455.
42. Santi L., Giritch A., Roy C.J., et al. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc. Natl Acad. Sci. U.S.A 2006, 103(4):861-866.
43. Santi L., Batchelor L., Huang Z., et al. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 2008, 26(15):1846-1854.
44. Sparrow P.A., Irwin J.A., Dale P.J., et al. Pharma-Planta: road testing the developing regulatory guidelines for plant-made pharmaceuticals. Transgenic Res. 2007, 16(2):147-161.
45. Timmermans M.C.P., Das O.P., Messing J. Geminiviruses and Their Uses as Extrachromosomal Replicons. Annu. Rev. Plant Phys. Plant Mol. Bio. 1994, 45:79-112.
46. Turpen T.H., Reinl S.J., Charoenvit Y., et al. Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus. Biotechnology (N.Y.) 1995, 13(1):53-57.
47. Wagner B., Fuchs H., Adhami F., et al. Plant virus expression systems for transient production of recombinant allergens in Nicotiana benthamiana. Methods 2004, 32:227-234.
48. Webster D.E., Wang L., Mulcair M., et al. Production and characterization of an orally immunogenic Plasmodium antigen in plants using a virus-based expression system. Plant Biotechnol. J. 2009, 7(9):846-855.
49. Wigdorovitz A., Carrillo C., DusSantos M.J., et al. Induction of A protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 1999, 255(2):347-353.
50. Yusibov V., Shivprasad S., Turpen T.H., et al. Plant viral vectors based on tobamoviruses. Curr. Top. Microbiol. Immunol. 1999, 240:81-94.
51. Yusibov V., Streatfield S.J., Kushnir N. Clinical development of plant-produced recombinant pharmaceuticals: vaccines, antibodies and beyond. Hum. Vaccin. 2011, 7(3):313-321.